Cc1oc2ccc(O)c(CN3CCN(C)CC3)c2c1C(=O)Nc1ccc(C(C)C)cc1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?